All News about Xenon Pharmaceuticals Inc
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Reports Q2 2024 Financial Results and Business Update
August 08, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Xenon Pharmaceuticals
February 28, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
4 Analysts Have This to Say About Xenon Pharmaceuticals
December 08, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/laboratory-563423-1920_9.jpeg?width=1200&height=800&fit=crop)
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
January 08, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://www.marketbeat.com/logos/articles/med_20231228125224_bristol-myers-squibbs-big-buys-18.jpg)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/11/30/2.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.